🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Laura Else

Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology University of Liverpool Liverpool UK

ORCID: 0009-0007-0078-3294

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing”.

Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing

Journal of Antimicrobial Chemotherapy(2024)10.1093/jac/dkae147
N/A
0.316DataRank · unranked
5 citations

Laura Dickinson, Stacey Edick, Ashley Zyhowski, Ken Ho, Leslie A. Meyn +6 more

Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP PK study

Antiviral Research(2024)10.1016/j.antiviral.2024.106014
N/A
0.269DataRank · unranked
5 citations

Sumaya Dadan, Kalisha Bheemraj, Catriona Waitt, Saye Khoo, Landon Myer +8 more

PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing

Clinical Pharmacology & Therapeutics(2026)10.1002/cpt.70206
N/A
0.165DataRank · unranked
2 citations

Prajith Venkatasubramanian, Abdulafeez Akinloye, Oluwasegun Eniayewu, Brookie M. Best, Laura Else +2 more

An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2

medRxiv(2021)10.1101/2021.09.10.21263376
N/A
0DataRank · unranked
0 citations

Richard J. Fitzgerald, Geoffrey Saunders, Rebecca Lyon, Michael Fisher, Karen Martin +27 more